New study explores weight loss and hormones before cancer surgery for better results
NCT ID NCT07462663
First seen Mar 10, 2026 · Last updated Jun 18, 2026 · Updated 19 times
Summary
This study tests whether a 28- to 54-week pre-surgery program—including weight-loss medication, a hormone-releasing IUD, nutrition, and exercise—can safely improve outcomes for women with early-stage endometrial cancer and a BMI of 40 or higher. About 80 participants will be randomly assigned to either standard immediate surgery or the pre-surgery program. The goal is to see if the program is feasible, safe, and acceptable, and whether it reduces surgical risks without allowing the cancer to progress.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.